GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,438.90
+22.20 (0.92%)
May 15, 2026, 3:29 PM IST

NSE:GLAXO Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
10,3609,2765,9006,10716,947
Depreciation & Amortization
664.4565.7591.43560.73587.16
Other Amortization
-102.22105.3796.9494.7
Loss (Gain) From Sale of Assets
0.515.13-8.89-0.28-3.24
Loss (Gain) From Sale of Investments
-796.3-696.5-487.76-307.79-5.92
Provision & Write-off of Bad Debts
18.923.765.87-73.641.62
Other Operating Activities
-232.61,765-895.67-1,124-11,442
Change in Accounts Receivable
175.5-728.68-302.69202.28102.04
Change in Inventory
241.8433.11-650.78747.25120.03
Change in Accounts Payable
-1,389769.691,901-1,5321,024
Change in Other Net Operating Assets
-10.41,374-337.69125.16-47.1
Operating Cash Flow
9,03312,8995,8204,8428,107
Operating Cash Flow Growth
-29.97%121.63%20.20%-40.27%40.29%
Capital Expenditures
-552.8-230.22-312.22-440.39-346.41
Sale of Property, Plant & Equipment
220.357.17224.5614.5711.77
Sale (Purchase) of Real Estate
---97.8323.42
Investment in Securities
3,172-1,444-1,4549,563-18,124
Other Investing Activities
1,1311,1591,629-1,15614,080
Investing Cash Flow
3,970-458.0187.128,079-4,055
Long-Term Debt Repaid
-203.7-187.31-181.25-168.68-156.18
Net Debt Issued (Repaid)
-203.7-187.31-181.25-168.68-156.18
Common Dividends Paid
-7,140-7,494-5,416-15,255-5,066
Other Financing Activities
-27.4-13.14-17.99-9.55-19.9
Financing Cash Flow
-7,371-7,694-5,615-15,433-5,242
Net Cash Flow
5,6324,747292.3-2,512-1,190
Free Cash Flow
8,48012,6695,5084,4027,761
Free Cash Flow Growth
-33.06%130.01%25.13%-43.28%45.42%
Free Cash Flow Margin
21.38%33.79%15.95%13.54%23.68%
Free Cash Flow Per Share
50.0574.7832.5125.9845.81
Cash Interest Paid
-13.1417.9913.9817.37
Cash Income Tax Paid
29.5823.792,3492,6461,195
Levered Free Cash Flow
8,30011,6246,7011,56210,097
Unlevered Free Cash Flow
8,31711,6326,7121,57310,109
Change in Working Capital
-981.71,848610.21-457.461,199
Source: S&P Global Market Intelligence. Standard template. Financial Sources.